Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a ...

Join Ramzan Karmali as he takes a closer look at today's Trending stock Tickers - Adidas, the sportswear giant - Novo Nordisk ...

Novo Nordisk A/S’s best-sellers Ozempic and Wegovy transformed the firm into a global pharmaceutical giant. But four years ...

July 29 - Novo Nordisk (NOVO?B) shares plunged about 20% Tuesday after the Danish drugmaker warned of weaker-than?expected ...

Novo Nordisk A/S shares plunged after a Q2 revenue update and 2025 guidance downgrade. Click here to find out why NVO stock ...

Novo Nordisk stocks plunged by 7% in premarket trading following an announcement by the company that it has lowered its ...

Novo Nordisk’s shares plunged more than a fifth on Tuesday, wiping more than €60bn from its value, after it slashed sales and profit forecasts for the year amid competition from US copycat weight-loss ...

The maker of GLP-1 drugs Ozempic and Wegovy cut sales grown from 13%-21% down to 8%-14% for the year. That's about half, on the higher end, of the 26% growth seen in 2024. Outgoing CEO Lars Jøregensen ...

Drugmaker struggled to adapt to very high demand and a market where celebrities are more influential than doctors ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Indiana saw the second biggest small business growth in July, while President Trump is expected to impose tariffs on medicine ...

These semaglutide drugs became so popular after their efficacy for weight loss became apparent that, in a sense, they became ...